老年人药物治疗案例系列:糖尿病药物-重点关注二次中风预防
Sabrina Warren1, Shayla McKee1, Erin Yakiwchuk1
1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
The Senior care pharmacist
|October 3, 2024
概括
本综述检查了糖尿病药物用于降低中风风险. 虽然SGLT-2抑制剂和GLP-1受体激动剂显示出心血管方面的益处,但特定的中风数据有限,这突出了针对性研究的需要.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 糖尿病和脑血管疾病经常共存,对患病率和死亡率作出重大贡献,特别是在老年人中.
- 已经确定的SGLT-2抑制剂和GLP-1受体激动剂对心血管有好处,但临床试验通常使用复合终点,不隔离中风风险.
- 在有中风病史的患者中,管理糖尿病需要仔细考虑血糖控制和脑血管风险降低.
研究的目的:
- 审查各种糖尿病药物降低中风风险的证据.
- 为了告知糖尿病管理方案的选择,以优化血糖控制和最大限度地降低中风风险.
- 突出患者特异性因素在患有脑血管疾病的个体中糖尿病管理的重要性.
主要方法:
- 文献综述侧重于临床试验和有关糖尿病药物和中风风险的证据.
- 对检查SGLT-2抑制剂和GLP-1受体激动剂对心血管结果的研究进行分析,并关注中风特定数据.
- 以糖尿病和多次中风患者为灵感的案例审查方法,以说明临床决策.
主要成果:
- 有证据表明,SGLT-2抑制剂和GLP-1受体激活剂可能会降低中风风险,但并不总是作为主要终点.
- 其他糖尿病药物对中风风险的具体影响需要进一步调查.
- 个体患者的因素,如中风病史,显著影响治疗选择.
结论:
- 在患有脑血管疾病的患者中,适当的糖尿病管理需要对血糖控制和降低中风风险的双重重点.
- 需要进一步的研究来澄清各种糖尿病药物的中风特异性益处.
- 整合当前证据和患者特定因素的个性化治疗计划对于这一群体的最佳结果至关重要.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
209
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
1.4K
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
181
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
181
01:24Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
01:27Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
01:23Atherosclerosis IV: Nursing Management
2
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
2